The analysis underscores a rapidly increasing burden of cardio-renal metabolic conditions, with high prevalence of diabetes, hypertension, and kidney disease. Fragmented screening pathways, gaps in care continuity, and disparities in access, particularly across states and populations, emerge as key challenges shaping outcomes.